Assyro AI

Orange Book product · Brand (NDA)

IMPOYZ

CLOBETASOL PROPIONATE

Brand (NDA)NDA 209483RX PRIMUS PHARMS
View CLOBETASOL PROPIONATE familyOpen on FDA Orange Book

At a glance

Nov 28, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

14

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 28, 2017

    8 yr 8 mo ago

  2. Today

  3. Patent 10064875 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  4. Patent 10064875 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  5. Patent 10064875 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  6. Patent 10064875 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  7. Patent 10064875 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  8. Patent 10588914 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  9. Patent 11179465 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  10. Patent 9956231 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  11. Patent 9956231 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  12. Patent 9956231 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  13. Patent 9956231 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  14. Patent 9956231 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  15. Patent 9956231 expires

    Listed drug product patent expiration.

    Aug 31, 2030

    in 4 yr 3 mo

  16. Patent 9855334 expires

    Listed drug product patent expiration.

    Mar 11, 2035

    in 8 yr 10 mo

Pharmaceutical detail

Active ingredient

CLOBETASOL PROPIONATE

Strength

0.025%

Dosage form

CREAM

Route

TOPICAL

TE code

Not listed

Application

NDA 209483

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (14)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10064875Aug 31, 2030in 4 yr 3 mo
ProductU-88
10064875Aug 31, 2030in 4 yr 3 mo
ProductU-1858
10064875Aug 31, 2030in 4 yr 3 mo
ProductU-193
10064875Aug 31, 2030in 4 yr 3 mo
ProductU-1408
10064875Aug 31, 2030in 4 yr 3 mo
ProductU-742
10588914Aug 31, 2030in 4 yr 3 mo
ProductU-2771
11179465Aug 31, 2030in 4 yr 3 mo
ProductU-1858
9956231Aug 31, 2030in 4 yr 3 mo
ProductU-88
9956231Aug 31, 2030in 4 yr 3 mo
ProductU-1408
9956231Aug 31, 2030in 4 yr 3 mo
ProductU-193
9956231Aug 31, 2030in 4 yr 3 mo
ProductU-742
9956231Aug 31, 2030in 4 yr 3 mo
ProductU-1858
9956231Aug 31, 2030in 4 yr 3 mo
ProductU-1761
9855334Mar 11, 2035in 8 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo